380 related articles for article (PubMed ID: 33652261)
1. Akebia saponin D ameliorates metabolic syndrome (MetS) via remodeling gut microbiota and attenuating intestinal barrier injury.
Yang S; Hu T; Liu H; Lv YL; Zhang W; Li H; Xuan L; Gong LL; Liu LH
Biomed Pharmacother; 2021 Jun; 138():111441. PubMed ID: 33652261
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
3. Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis
Liu MT; Huang YJ; Zhang TY; Tan LB; Lu XF; Qin J
World J Gastroenterol; 2019 Jul; 25(27):3590-3606. PubMed ID: 31367159
[TBL] [Abstract][Full Text] [Related]
4. A review of saponin intervention in metabolic syndrome suggests further study on intestinal microbiota.
Luo Z; Xu W; Zhang Y; Di L; Shan J
Pharmacol Res; 2020 Oct; 160():105088. PubMed ID: 32683035
[TBL] [Abstract][Full Text] [Related]
5. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
Wang P; Wang J; Li D; Ke W; Chen F; Hu X
J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
[TBL] [Abstract][Full Text] [Related]
6. Phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity.
Zhang XY; Chen J; Yi K; Peng L; Xie J; Gou X; Peng T; Tang L
Gut Microbes; 2020 Nov; 12(1):1-18. PubMed ID: 33222603
[TBL] [Abstract][Full Text] [Related]
7. High-fat diet impairs gut barrier through intestinal microbiota-derived reactive oxygen species.
Zeng N; Wu F; Lu J; Li X; Lin S; Zhou L; Wang Z; Wu G; Huang Q; Zheng D; Gao J; Wu S; Chen X; Chen M; Meng F; Shang H; He Y; Chen P; Wei H; Li Z; Zhou H
Sci China Life Sci; 2024 May; 67(5):879-891. PubMed ID: 37202543
[TBL] [Abstract][Full Text] [Related]
8. Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota.
Zhou D; Pan Q; Shen F; Cao HX; Ding WJ; Chen YW; Fan JG
Sci Rep; 2017 May; 7(1):1529. PubMed ID: 28484247
[TBL] [Abstract][Full Text] [Related]
9. Lactobacillus plantarum NA136 ameliorates nonalcoholic fatty liver disease by modulating gut microbiota, improving intestinal barrier integrity, and attenuating inflammation.
Zhao Z; Chen L; Zhao Y; Wang C; Duan C; Yang G; Niu C; Li S
Appl Microbiol Biotechnol; 2020 Jun; 104(12):5273-5282. PubMed ID: 32335723
[TBL] [Abstract][Full Text] [Related]
10. Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.
Wang W; Zhao J; Gui W; Sun D; Dai H; Xiao L; Chu H; Du F; Zhu Q; Schnabl B; Huang K; Yang L; Hou X
Br J Pharmacol; 2018 Feb; 175(3):469-484. PubMed ID: 29139555
[TBL] [Abstract][Full Text] [Related]
11. The metabolic and vascular protective effects of olive (Olea europaea L.) leaf extract in diet-induced obesity in mice are related to the amelioration of gut microbiota dysbiosis and to its immunomodulatory properties.
Vezza T; Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Romero M; Sánchez M; Toral M; Martín-García B; Gómez-Caravaca AM; Arráez-Román D; Segura-Carretero A; Micol V; García F; Utrilla MP; Duarte J; Rodríguez-Cabezas ME; Gálvez J
Pharmacol Res; 2019 Dec; 150():104487. PubMed ID: 31610229
[TBL] [Abstract][Full Text] [Related]
12. Akebia Saponin D Regulates the Metabolome and Intestinal Microbiota in High Fat Diet-Induced Hyperlipidemic Rats.
Zhou P; Yang X; Yang Z; Huang W; Kou J; Li F
Molecules; 2019 Apr; 24(7):. PubMed ID: 30939835
[TBL] [Abstract][Full Text] [Related]
13. Ophiopogonin D alleviates high-fat diet-induced metabolic syndrome and changes the structure of gut microbiota in mice.
Chen S; Li X; Liu L; Liu C; Han X
FASEB J; 2018 Mar; 32(3):1139-1153. PubMed ID: 29084766
[TBL] [Abstract][Full Text] [Related]
14. Bletilla striata oligosaccharides improve metabolic syndrome through modulation of gut microbiota and intestinal metabolites in high fat diet-fed mice.
Hu B; Ye C; Leung EL; Zhu L; Hu H; Zhang Z; Zheng J; Liu H
Pharmacol Res; 2020 Sep; 159():104942. PubMed ID: 32504835
[TBL] [Abstract][Full Text] [Related]
15. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
[TBL] [Abstract][Full Text] [Related]
16. Citrus polymethoxyflavones attenuate metabolic syndrome by regulating gut microbiome and amino acid metabolism.
Zeng SL; Li SZ; Xiao PT; Cai YY; Chu C; Chen BZ; Li P; Li J; Liu EH
Sci Adv; 2020 Jan; 6(1):eaax6208. PubMed ID: 31922003
[TBL] [Abstract][Full Text] [Related]
17. Luteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis.
Liu X; Sun R; Li Z; Xiao R; Lv P; Sun X; Olson MA; Gong Y
Arch Biochem Biophys; 2021 Oct; 711():109019. PubMed ID: 34478730
[TBL] [Abstract][Full Text] [Related]
18. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.
Mouries J; Brescia P; Silvestri A; Spadoni I; Sorribas M; Wiest R; Mileti E; Galbiati M; Invernizzi P; Adorini L; Penna G; Rescigno M
J Hepatol; 2019 Dec; 71(6):1216-1228. PubMed ID: 31419514
[TBL] [Abstract][Full Text] [Related]
19. Fubrick tea attenuates high-fat diet induced fat deposition and metabolic disorder by regulating gut microbiota and caffeine metabolism.
Jing N; Liu X; Jin M; Yang X; Hu X; Li C; Zhao K
Food Funct; 2020 Aug; 11(8):6971-6986. PubMed ID: 32697259
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an
Carbajo-Pescador S; Porras D; García-Mediavilla MV; Martínez-Flórez S; Juarez-Fernández M; Cuevas MJ; Mauriz JL; González-Gallego J; Nistal E; Sánchez-Campos S
Dis Model Mech; 2019 Apr; 12(5):. PubMed ID: 30971408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
